These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 32642255)

  • 21. Sputum microRNA biomarkers for identifying lung cancer in indeterminate solitary pulmonary nodules.
    Xing L; Su J; Guarnera MA; Zhang H; Cai L; Zhou R; Stass SA; Jiang F
    Clin Cancer Res; 2015 Jan; 21(2):484-9. PubMed ID: 25593345
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Validation of the BRODERS classifier (Benign
    Maldonado F; Varghese C; Rajagopalan S; Duan F; Balar AB; Lakhani DA; Antic SL; Massion PP; Johnson TF; Karwoski RA; Robb RA; Bartholmai BJ; Peikert T
    Eur Respir J; 2021 Apr; 57(4):. PubMed ID: 33303552
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Liquid biopsies to distinguish malignant from benign pulmonary nodules.
    Tao R; Cao W; Zhu F; Nie J; Wang H; Wang L; Liu P; Chen H; Hong B; Zhao D
    Thorac Cancer; 2021 Jun; 12(11):1647-1655. PubMed ID: 33960710
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Computer-aided diagnostic scheme for distinction between benign and malignant nodules in thoracic low-dose CT by use of massive training artificial neural network.
    Suzuki K; Li F; Sone S; Doi K
    IEEE Trans Med Imaging; 2005 Sep; 24(9):1138-50. PubMed ID: 16156352
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peripheral pulmonary nodules: relationship between multi-slice spiral CT perfusion imaging and tumor angiogenesis and VEGF expression.
    Ma SH; Le HB; Jia BH; Wang ZX; Xiao ZW; Cheng XL; Mei W; Wu M; Hu ZG; Li YG
    BMC Cancer; 2008 Jun; 8():186. PubMed ID: 18590539
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Conventional Computed Tomographic Calcium Scoring vs full chest CTCS for lung cancer screening: a cost-effectiveness analysis.
    Jiang B; Linden PA; Gupta A; Jarrett C; Worrell SG; Ho VP; Perry Y; Towe CW;
    BMC Pulm Med; 2020 Jul; 20(1):187. PubMed ID: 32631384
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 18F-FSPG PET imaging for the evaluation of indeterminate pulmonary nodules.
    Paez R; Shah C; Cords AJ; Muterspaugh A; Helton JE; Antic S; Eisenberg R; Chen H; Grogan EL; Manning HC; Walker RC; Massion PP
    PLoS One; 2022; 17(3):e0265427. PubMed ID: 35294486
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lung cancer prediction by Deep Learning to identify benign lung nodules.
    Heuvelmans MA; van Ooijen PMA; Ather S; Silva CF; Han D; Heussel CP; Hickes W; Kauczor HU; Novotny P; Peschl H; Rook M; Rubtsov R; von Stackelberg O; Tsakok MT; Arteta C; Declerck J; Kadir T; Pickup L; Gleeson F; Oudkerk M
    Lung Cancer; 2021 Apr; 154():1-4. PubMed ID: 33556604
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biomarkers for early diagnosis, prognosis, prediction, and recurrence monitoring of non-small cell lung cancer.
    Tang Y; Qiao G; Xu E; Xuan Y; Liao M; Yin G
    Onco Targets Ther; 2017; 10():4527-4534. PubMed ID: 28979144
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combining serum miRNAs, CEA, and CYFRA21-1 with imaging and clinical features to distinguish benign and malignant pulmonary nodules: a pilot study : Xianfeng Li et al.: Combining biomarker, imaging, and clinical features to distinguish pulmonary nodules.
    Li X; Zhang Q; Jin X; Cao L
    World J Surg Oncol; 2017 May; 15(1):107. PubMed ID: 28545454
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Machine learning approach for distinguishing malignant and benign lung nodules utilizing standardized perinodular parenchymal features from CT.
    Uthoff J; Stephens MJ; Newell JD; Hoffman EA; Larson J; Koehn N; De Stefano FA; Lusk CM; Wenzlaff AS; Watza D; Neslund-Dudas C; Carr LL; Lynch DA; Schwartz AG; Sieren JC
    Med Phys; 2019 Jul; 46(7):3207-3216. PubMed ID: 31087332
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LUCIS: lung cancer imaging studies.
    Harders SW
    Dan Med J; 2012 Nov; 59(11):B4542. PubMed ID: 23171752
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A simple assessment of lung nodule location for reduction in unnecessary invasive procedures.
    Kinsey CM; Billatos E; Mori V; Tonelli B; Cole BF; Duan F; Marques H; de la Bruere I; Onieva J; San José Estépar R; Cleveland A; Idelkope D; Stevenson C; Bates JHT; Aberle D; Spira A; Washko G; San José Estépar R
    J Thorac Dis; 2021 Jul; 13(7):4207-4216. PubMed ID: 34422349
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Putting artificial intelligence (AI) on the spot: machine learning evaluation of pulmonary nodules.
    Tandon YK; Bartholmai BJ; Koo CW
    J Thorac Dis; 2020 Nov; 12(11):6954-6965. PubMed ID: 33282401
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Pursuit of Noninvasive Diagnosis of Lung Cancer.
    Atwater T; Cook CM; Massion PP
    Semin Respir Crit Care Med; 2016 Oct; 37(5):670-680. PubMed ID: 27732989
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The utility of a convolutional neural network (CNN) model score for cancer risk in indeterminate small solid pulmonary nodules, compared to clinical practice according to British Thoracic Society guidelines.
    Tsakok MT; Mashar M; Pickup L; Peschl H; Kadir T; Gleeson F
    Eur J Radiol; 2021 Apr; 137():109553. PubMed ID: 33581913
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnosing the indeterminate pulmonary nodule: percutaneous biopsy versus thoracoscopy.
    Mitruka S; Landreneau RJ; Mack MJ; Fetterman LS; Gammie J; Bartley S; Sutherland SR; Bowers CM; Keenan RJ; Ferson PF
    Surgery; 1995 Oct; 118(4):676-84. PubMed ID: 7570322
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Do we need to see to believe?-radiomics for lung nodule classification and lung cancer risk stratification.
    Khawaja A; Bartholmai BJ; Rajagopalan S; Karwoski RA; Varghese C; Maldonado F; Peikert T
    J Thorac Dis; 2020 Jun; 12(6):3303-3316. PubMed ID: 32642254
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Angiogenesis Biomarkers May Be Useful in the Management of Patients With Indeterminate Pulmonary Nodules.
    Seder CW; Kubasiak JC; Pithadia R; Basu S; Fhied C; Tarhoni I; Davila E; Alnajjar H; Chmielewski GW; Warren WH; Liptay MJ; Borgia JA
    Ann Thorac Surg; 2015 Aug; 100(2):429-36. PubMed ID: 26138771
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A model based on the quantification of complement C4c, CYFRA 21-1 and CRP exhibits high specificity for the early diagnosis of lung cancer.
    Ajona D; Remirez A; Sainz C; Bertolo C; Gonzalez A; Varo N; Lozano MD; Zulueta JJ; Mesa-Guzman M; C Martin A; Perez-Palacios R; Perez-Gracia JL; Massion PP; Montuenga LM; Pio R
    Transl Res; 2021 Jul; 233():77-91. PubMed ID: 33618009
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.